Safe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy
Author:
Affiliation:
1. Department of Endocrine Neoplasia & Hormonal Disorders, Division of Internal Medicine, University of Texas–MD Anderson Cancer Center, Houston, Texas.
2. Department of Biostatistics, University of Texas–MD Anderson Cancer Center, Houston, Texas.
Publisher
Mary Ann Liebert Inc
Subject
Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.liebertpub.com/doi/pdf/10.1089/dia.2014.0115
Reference12 articles.
1. Influence des polypathologies sur le traitement des hémopathies malignes
2. Do Corticosteroids Provide Analgesic Effects in Cancer Patients? A Systematic Literature Review
3. Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy
4. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate–cytarabine regimen
5. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inpatient diabetes management;Annals of the New York Academy of Sciences;2024-07-25
2. Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatment;Cancer Treatment Reviews;2024-05
3. Chronic hyperglycemia and intracranial meningiomas;BMC Cancer;2024-04-17
4. Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study;SAGE Open Medicine;2024-01
5. Assessing Risk Classification in Medication-Induced Diabetes during Induction Therapy in Pediatric Acute Lymphoblastic Leukemia;Pediatric Diabetes;2023-12-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3